MFG
CKPT

Magnus Financial Group’s Checkpoint Therapeutics CKPT Stock Holding History

Magnus Financial Group’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,200
Closed -$103K – 371
2024
Q4 		$103K Sell
32,200
-2,800
-8% -$9.49K 0.01% 353
2024
Q3 		$78.4K Buy
35,000
+4,000
+13% +$9.23K 0.01% 335
2024
Q2 		$66.7K Buy
31,000
+1,000
+3% +$1.78K 0.01% 314
2024
Q1 		$61.5K Buy
30,000
+6,000
+25% +$12K 0.01% 311
2023
Q4 		$55K Buy
+24,000
New +$52.3K 0.01% 285

Other funds holding CKPT

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return

Magnus Financial Group's CKPT Position: Q1 2025 in Review

Magnus Financial Group sold out of Checkpoint Therapeutics (CKPT) in Q1 2025, closing a stake of 32,200 shares — an estimated $103K sold.

Magnus Financial Group first reported a position in CKPT in Q4 2023 and held it in 5 quarters. The position peaked at $103K in Q4 2024. 84 funds tracked by Wall St. Rank hold CKPT as of Q1 2025.

  • Magnus Financial Group reported no remaining Checkpoint Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Magnus Financial Group sold 32,200 Checkpoint Therapeutics shares in Q1 2025, an estimated $103K.
  • Magnus Financial Group first reported a position in Checkpoint Therapeutics in Q4 2023 and held it in 5 quarters.
  • Magnus Financial Group's Checkpoint Therapeutics position peaked at $103K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2025.

Based on Magnus Financial Group's 13F filing for Q1 2025, filed 11 Apr 2025.